Skip to main content

Refine your results

Filters

Displaying 1221 - 1240 of 1516

Cases and Proceedings

Pfizer Inc. and Pharmacia Corporation

A final consent order permits Pfizer Inc.'s acquisition of Phamacia Corporation while requiring the divestiture of various products including extended release drugs used in the treatment of an overactive bladder; hormone replacement therapies; erectile dysfunction; canine arthritis; and motion sickness. Novartis AG, Neurocrine Biosciences, Inc., Schering-Plough Corporation, Johnson & Johnson, Insight Pharmaceuticals Corporation, and Cadbury Schweppes are named in the order as potential buyers of the various pharmaceuticals and products.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
021 0192
Docket Number
C-4075
Cases and Proceedings

Quest Diagnostics Inc.orporated and Unilab Corporation

Quest Diagnostics settled FTC charges that its proposed acquisition of Unilab Corporation would substantially increase concentration in the clinical laboratory testing services market by agreeing to divest clinical laboratory testing assets in Northern California to Laboratory Corporation of America.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0210140
Docket Number
C-4074
Press Release

Announced Actions for March 18, 2003

Date
The Commission has received a petition from Solvay S.A. (Solvay) to reopen and modify the Commission's hold separate order regarding Solvay's acquisition of Ausimont S.p.A. In its petition, which is...
Feb26
Event

Health Care and Competition Law and Policy Hearings

-
The Federal Trade Commission and Department of Justice will commence public hearings in Washington, D.C. on February 26, 2003 on the implications of competition law and policy for health care...

Displaying 1221 - 1240 of 1516

Return to top